Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022

SELL
$117.13 - $176.59 $232,971 - $351,237
-1,989 Closed
0 $0
Q1 2022

Apr 26, 2022

BUY
$126.46 - $235.05 $251,528 - $467,514
1,989 New
1,989 $343,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Nvest Financial, LLC Portfolio

Follow Nvest Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nvest Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nvest Financial, LLC with notifications on news.